Lymphoma: Clinico-pathological Findings and Outcome + Alk

نویسندگان

  • Leonardo Flenghi
  • Massimo F. Martelli
  • Antonella Santucci
  • Roberto Giardini
  • Antonella Aiello
  • Hans-Dieter Foss
  • Iguacyra Araujo
  • Marco Fizzotti
  • Gregor Verhoef
  • Fabio Menestrina
  • Giuseppe Todeschini
  • Marco Paulli
  • Mario Lazzarino
  • Brunangelo Falini
  • Stefano Pileri
  • Pier Luigi Zinzani
  • Antonino Carbone
  • Vittorina Zagonel
  • Chris Wolf-Peeters
  • Pier-Giuseppe Pelicci
چکیده

Pelicci, Leonardo Flenghi, Massimo F. Martelli and Antonella Santucci Roberto Giardini, Antonella Aiello, Hans-Dieter Foss, Iguacyra Araujo, Marco Fizzotti, Pier-Giuseppe Wolf-Peeters, Gregor Verhoef, Fabio Menestrina, Giuseppe Todeschini, Marco Paulli, Mario Lazzarino, Brunangelo Falini, Stefano Pileri, Pier Luigi Zinzani, Antonino Carbone, Vittorina Zagonel, Chris Lymphoma: Clinico-Pathological Findings and Outcome + ALK

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

NEOPLASIA ALK 1 Lymphoma : Clinico - Pathological Findings and Outcome

A distinct pathologic entity (ALK1 lymphoma) that is characterized by expression of the anaplastic lymphoma kinase (ALK) protein has recently emerged within the heterogeneous group of CD301 anaplastic large-cell lymphomas. Information on clinical findings and treatment outcome of ALK1 lymphoma is still limited, and no data are available concerning the value of the International Prognostic Index...

متن کامل

Hodgkin Lymphoma and Anaplastic Variants of Non-Hodgkin Lymphoma

  Background and Objectives: Classic Hodgkin lymphoma (CHL), anaplastic large cell lymphoma (ALCL) and some cases of diffuse large B cell lymphoma (DLBCL) have overlapping morphologic features. Since they all represent distinct clinico-pathologic entities, we explored the differential diagnostic impact of immunophenotyping to discriminate between them. Materials and Methods:...

متن کامل

Among diffuse large B-cell lymphomas, T-cell-rich/histiocyte-rich BCL and CD30+ anaplastic B-cell subtypes exhibit distinct clinical features.

BACKGROUND The EORTC clinical trial 20901, activated in 1990, was designed to treat non-Hodgkin's lymphomas (NHL) of intermediate/high-grade malignancy according to the Working Formulation. Established in 1994, the R.E.A.L. Classification on NHL has now replaced all former classifications. PATIENTS AND METHODS We reanalysed all cases (n = 273) documented by material available for review accor...

متن کامل

Anaplastic lymphoma kinase-positive large B-cell lymphoma: Clinico-pathological study of 17 cases with review of literature

We retrospectively analysed 17 cases of anaplastic lymphoma kinase-positive large B-cell lymphoma (ALK+, LBCL) according to the morphological, immunohistochemical, molecular and clinical features, using which we intend to elucidate the clinicopathological characteristics of this rare entity. In this study, all cases de facto share common features that defined them as a single entity, and variou...

متن کامل

Retrospective study of ALK rearrangement and clinicopathological implications in completely resected non- small cell lung cancer patients in Northern Thailand: role of screening with D5F3 antibodies.

BACKGROUND Anaplastic lymphoma kinase (ALK) gene rearrangement in non-small cell lung cancer (NSCLC) has been intensively studied. The gold standard for ALK detection is FISH, but this is not routinely conducted in clinical practice, so that the IHC method has a role. The aim of this study was to identify the incidence of ALK rearrangement and risk or prognostic factors for ALK positivity using...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 1999